Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects

NCT00954252 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CERESPIR